AC IMMUNE SA's ticker is ACIU and the CUSIP is H00263105. A total of 29 filers reported holding AC IMMUNE SA in Q3 2023. The put-call ratio across all filers is 1.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $441,428 | +26.9% | 154,887 | +31.6% | 0.00% | – |
| Q2 2023 | $347,932 | +1099.1% | 117,672 | +849.0% | 0.00% | – |
| Q1 2023 | $29,016 | -76.3% | 12,400 | -79.3% | 0.00% | – |
| Q4 2022 | $122,229 | +2.7% | 59,916 | +58.9% | 0.00% | – |
| Q3 2022 | $119,000 | -38.7% | 37,700 | -29.5% | 0.00% | – |
| Q2 2022 | $194,000 | -79.4% | 53,446 | -77.4% | 0.00% | – |
| Q1 2022 | $944,000 | -44.0% | 236,108 | -30.7% | 0.00% | – |
| Q4 2021 | $1,686,000 | -9.3% | 340,814 | +23.0% | 0.00% | – |
| Q3 2021 | $1,859,000 | -32.2% | 277,000 | -19.8% | 0.00% | – |
| Q2 2021 | $2,740,000 | -26.6% | 345,500 | -29.6% | 0.00% | – |
| Q1 2021 | $3,733,000 | -12.0% | 490,588 | -40.2% | 0.00% | – |
| Q4 2020 | $4,240,000 | +203.5% | 820,036 | +186.7% | 0.00% | – |
| Q3 2020 | $1,397,000 | +1714.3% | 286,059 | +2399.0% | 0.00% | – |
| Q2 2020 | $77,000 | – | 11,447 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,428,379 | $29,714,000 | 1.19% |
| ACUTA CAPITAL PARTNERS, LLC | 100,000 | $400,000 | 0.19% |
| Artal Group S.A. | 1,000,000 | $4,000,000 | 0.17% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,062,462 | $4,250,000 | 0.13% |
| Kingsbury Capital Investment Advisors LLC | 18,975 | $76,000 | 0.08% |
| EcoR1 Capital, LLC | 485,005 | $1,940,000 | 0.06% |
| Virtus ETF Advisers LLC | 31,014 | $124,000 | 0.06% |
| Eversept Partners, LP | 124,589 | $498,356 | 0.04% |
| COHEN LAWRENCE B | 12,850 | $51,000 | 0.03% |
| ALPINE WOODS CAPITAL INVESTORS, LLC | 50,000 | $200,000 | 0.02% |